Endoscopic evaluation and management of pancreatic duct strictures

https://doi.org/10.1016/j.tgie.2004.03.008Get rights and content

Pancreatic duct strictures, encountered at ERCP, may contribute to chronic pain of chronic pancreatitis or flares of acute pancreatitis. Once underlying malignancy is ruled out, endoscopic therapies similar to those used in the biliary tree may be applied. This paper reviews current methods used to evaluate these strictures, and discusses management strategies available to the therapeutic endoscopist.

Section snippets

Differential diagnosis

When a pancreatic duct stricture is encountered at endoscopic retrograde cholangiopancreatography (ERCP), the endoscopist faces a diagnostic dilemma as to the etiology of the stricture. While chronic pancreatitis is most likely in the alcoholic patient with a chronic pain syndrome, other possibilities include pancreatic neoplasms, pseudocysts and traumatic injury. Less frequently, mucus or protein plugs, or pancreatic stones may resemble a stricture. Pancreas divisum may also mimic a stricture

Therapy

While the pain in chronic pancreatitis is likely multifactorial in origin, pancreatic duct and parenchymal pressures are generally increased in chronic pancreatitis whether the main pancreatic duct is dilated or normal in diameter. Such elevated parenchymal and duct pressures contribute to pancreatic ischemia, which appears to play a significant role in the pain of chronic pancreatitis. Therapeutic efforts, therefore, are directed at reducing pancreatic parenchymal and ductal hypertension.

Complications associated with pancreatic stents

Several complications, both immediate and late, may occur after pancreatic duct stent placement, and are listed in Table 3. True complication rates are difficult to decipher, however, due to: 1) the simultaneous performance of other procedures (eg, pancreatic sphincterotomy, stricture dilation); 2) the heterogeneous patient populations treated (ie, patients with acute or chronic pancreatitis), and 3) the lack of uniform definitions of complications and a grading system of their severity.26 The

Conclusion

Endoscopic therapy of chronic pancreatitis and pancreatic duct strictures is an expanding area for the interventional endoscopist. The techniques employed are very similar to the endoscopic interventions utilized in the biliary tree but tend to be more tedious. Once appropriate evaluation (when applicable) has been performed to exclude pancreatic malignancy, the appropriate selection of candidates for pancreatic intervention appears to be important to obtain optimal results of therapy. Over the

References (31)

  • S. Sherman et al.

    Stent-induced pancreatic ductal and parenchymal changesCorrelation of endoscopic ultrasound with ERCP

    Gastrointest Endosc

    (1996)
  • A. Nakaizumi et al.

    Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy

    Hepatogastroenterology

    (1999)
  • M. Cremer et al.

    Stenting in severe chronic pancreatitisResults of medium-term follow-up in 76 patients

    Endoscopy

    (1991)
  • H. Grimm et al.

    New modalities for treating chronic pancreatitis

    Endoscopy

    (1989)
  • M. Cremer et al.

    Nonsurgical management of severe chronic pancreatitis

    Scand J Gastroenterol

    (1990)
  • Cited by (2)

    • Efficiency of pancreatic duct stenting therapy in children with chronic pancreatitis

      2014, Gastrointestinal Endoscopy
      Citation Excerpt :

      Retrospective evaluation showed that a better clinical outcome was achieved in patients who quit smoking.23 Fogel8 summarized results of pancreatic duct stent placement in 316 adult patients in a significant review of 7 studies, noting that the long-term efficacy of stenting therapy was 66%, with a 19% adverse event rate. The largest study of pancreatic duct stenting therapy was reported by Rösch et al,25 who investigated 1018 patients with CP undergoing interventional ERCP.

    View full text